Salinomycin Co-Treatment Enhances Tamoxifen Cytotoxicity in Luminal a Breast Tumor Cells by Facilitating Lysosomal Degradation of Receptor Tyrosine Kinases

Oncotarget - United States
doi 10.18632/oncotarget.10459
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Fibronectin Rescues Estrogen Receptor Α From Lysosomal Degradation in Breast Cancer Cells

Journal of Cell Biology
MedicineCell Biology
2018English

Tyrosine Kinase Signalling in Breast Cancer: ErbB Family Receptor Tyrosine Kinases

Breast Cancer Research
Cancer ResearchOncology
2000English

Signaling by Receptor Tyrosine Kinases

Annual Review of Biochemistry
Biochemistry
1993English

ErbB3 Downregulation Enhances Luminal Breast Tumor Response to Antiestrogens

Journal of Clinical Investigation
Medicine
2013English

Inhibiting PAD2 Enhances the Anti-Tumor Effect of Docetaxel in Tamoxifen-Resistant Breast Cancer Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Oxygen Tension Regulates Lysosomal Activation and Receptor Tyrosine Kinase Degradation

Cancers
Cancer ResearchOncology
2019English

C-Abl and Arg Tyrosine Kinases Regulate Lysosomal Degradation of the Oncoprotein Galectin-3

Cell Death and Differentiation
Cell BiologyMolecular Biology
2010English

Targeting the Receptor Tyrosine Kinase RET Sensitizes Breast Cancer Cells to Tamoxifen Treatment and Reveals a Role for RET in Endocrine Resistance

Oncogene
Cancer ResearchGeneticsMolecular Biology
2010English

Modulation of Tamoxifen Cytotoxicity by Caffeic Acid Phenethyl Ester in McF-7 Breast Cancer Cells

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy